This document summarizes the functionning of the Pharmaceutical industry by explaining the high cost of implementing a drug on the market. (time to market very long). High level of uncertainty. Thus, the companies have to be powerful and wealthy in order to resist and succeed in this particular business. This case study stresses on the GSK case who used to merger with small companies, but was it a merger too far?
Sommaire de l'étude de cas
Question 1: by using the Five Forces Framework, assess the threat of rivalry and the threat of entry in the pharmaceutical industry
Question 2: which factors explain the wave of mergers and acquisitions in the pharmaceutical industry?
Question 3: describe the way GSK has adapted the organization of its R&D activities. What are the advantages/drawbacks of the current organization of R&D activities?
À propos de l'auteur
Valentin L.Etudiant (stage)Politique économiquePharmaceutical industry (ex of GSK)